Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics

被引:241
作者
Melov, S
Doctrow, SR
Schneider, JA
Haberson, J
Patel, M
Coskun, PE
Huffman, K
Wallace, DC
Malfroy, B
机构
[1] Buck Inst Age Res, Novato, CA 94945 USA
[2] Eukar Inc, Bedford, MA 01730 USA
[3] Rush Presbyterian St Lukes Med Ctr, Rush Inst Healthy Aging, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Natl Jewish Med Res Inst, Denver, CO 80206 USA
[5] Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA
关键词
mitochondria; oxidative stress; superoxide dismutase; antioxidants; neurodegeneration; spongiform encephalopathy;
D O I
10.1523/JNEUROSCI.21-21-08348.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Superoxide is produced as a result of normal energy metabolism within the mitochondria and is scavenged by the mitochondrial form of superoxide dismutase (sod2). Mice with inactivated SOD2 (sod2 nullizygous mice) die prematurely, exhibiting several metabolic and mitochondrial defects and severe tissue pathologies, including a lethal spongiform neurodegenerative disorder (Li et al., 1995; Melov et al., 1998, 1999). We show that treatment of sod2 nullizygous mice with synthetic superoxide dismutase (SOD)-catalase mimetics extends their lifespan by threefold, rescues the spongiform encephalopathy, and attenuates mitochondrial defects. This class of antioxidant compounds has been shown previously to extend lifespan in the nematode Caenorhabditis elegans (Melov et al., 2000). These new findings in mice suggest novel therapeutic approaches to neurodegenerative diseases associated with oxidative stress such as Friedreich ataxia, spongiform encephalopathies, and Alzheimer's and Parkinson's diseases, in which chronic oxidative damage to the brain has been implicated.
引用
收藏
页码:8348 / 8353
页数:6
相关论文
共 41 条
[1]  
Baker K, 1998, J PHARMACOL EXP THER, V284, P215
[2]   SALEN-MANGANESE COMPLEXES ARE SUPEROXIDE DISMUTASE-MIMICS [J].
BAUDRY, M ;
ETIENNE, S ;
BRUCE, A ;
PALUCKI, M ;
JACOBSEN, EN ;
MALFROY, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) :964-968
[3]   Mitochondria, free radicals, and neurodegeneration [J].
Beal, MF .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (05) :661-666
[4]   The free radical theory of aging matures [J].
Beckman, KB ;
Ames, BN .
PHYSIOLOGICAL REVIEWS, 1998, 78 (02) :547-581
[5]   Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches [J].
Behl, C .
PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) :301-323
[6]  
BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
[7]   Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia [J].
Bradley, JL ;
Blake, JC ;
Chamberlain, S ;
Thomas, PK ;
Cooper, JM ;
Schapira, AHV .
HUMAN MOLECULAR GENETICS, 2000, 9 (02) :275-282
[8]   Normal prion protein has an activity like that of superoxide dismutase [J].
Brown, DR ;
Wong, BS ;
Hafiz, F ;
Clive, C ;
Haswell, SJ ;
Jones, IM .
BIOCHEMICAL JOURNAL, 1999, 344 :1-5
[9]   HYDROPEROXIDE METABOLISM IN MAMMALIAN ORGANS [J].
CHANCE, B ;
SIES, H ;
BOVERIS, A .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :527-605
[10]   Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].
Cherny, RA ;
Atwood, CS ;
Xilinas, ME ;
Gray, DN ;
Jones, WD ;
McLean, CA ;
Barnham, KJ ;
Volitakis, I ;
Fraser, FW ;
Kim, YS ;
Huang, XD ;
Goldstein, LE ;
Moir, RD ;
Lim, JT ;
Beyreuther, K ;
Zheng, H ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
NEURON, 2001, 30 (03) :665-676